Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas-Based Nanobiosensor Using Plasmonic Nanomaterials to Detect Disease Biomarkers

13 Feb 2025

Abstract excerpt

The development of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein (Cas) technology (CRISPR/Cas) as a gene-editing tool has the potential to revolutionize nucleic acid analysis. Recently, CRISPR/Cas systems have demonstrated considerable promise in the development of biosensors for the detection of essential disease biomarkers because they exhibit nonspecific...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced biosensing and bioanalysis techniques
Share to CRISPR and Genetic Engineering
Share to Mosquito-borne diseases and control

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40575544
DOI: 10.1007/s13206-024-00183-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 16 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas-Based Nanobiosensor Using Plasmonic Nanomaterials to Detect Disease BiomarkersPMID 40575544Read ↗

CRISPR/Cas Systems‐Inspired Nano/Biosensors for Detecting Infectious Viruses and Pathogenic BacteriaSemantic proximity Read ↗

Programmable Biosensors Based on RNA-Guided CRISPR/Cas EndonucleaseSemantic proximity Read ↗

CRISPR/Cas-based nucleic acid detection strategies: Trends and challengesSemantic proximity Read ↗

CRISPR‐Cas system for biomedical diagnostic platformsSemantic proximity Read ↗

Nucleic Acid Detection Using CRISPR/Cas Biosensing TechnologiesSemantic proximity Read ↗

CRISPR-cas technology: A key approach for SARS-CoV-2 detectionSemantic proximity Read ↗

CRISPR-Cas13a system: A novel tool for molecular diagnosticsSemantic proximity Read ↗

Recent Advances in CRISPR/Cas System-Based Biosensors for the Detection of Foodborne Pathogenic MicroorganismsSemantic proximity Read ↗

Research progress of CRISPR/Cas systems in nucleic acid detection of infectious diseasesSemantic proximity Read ↗

CRISPR in clinical diagnostics: bridging the gap between research and practice.Semantic proximity Read ↗

The CRISPR–Cas toolbox for analytical and diagnostic assay developmentSemantic proximity Read ↗

CRISPR-based diagnostics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.